[Intracranial manifestation of lymphomatoid granulomatosis (Liebow's disease)].

Radiologe

Institut für Nuklearmedizin des Deutschen Krebsforschungszentrums Heidelberg.

Published: August 1987

An intracranial manifestation of lymphomatoid granulomatosis occurs in 20% of patients. In the case of a 56-year-old patient it is shown that a relative long period can pass from the first neurological symptoms to histological diagnosis by stereotactic brain puncture. Over 15 months, follow-up studies were performed using computed tomography and magnetic resonance.

Download full-text PDF

Source

Publication Analysis

Top Keywords

manifestation lymphomatoid
8
lymphomatoid granulomatosis
8
[intracranial manifestation
4
granulomatosis liebow's
4
liebow's disease]
4
disease] intracranial
4
intracranial manifestation
4
granulomatosis occurs
4
occurs 20%
4
20% patients
4

Similar Publications

Article Synopsis
  • The text discusses the classification of Cutaneous T-cell Lymphomas (CTCL), highlighting the prevalence of CD4+ T-helper cell variants and a spectrum of CD8+ variants with various clinical and histological features.
  • CD8 and cytotoxic molecules can be identified through immunohistochemical staining, but their presence alone is not enough for diagnosis or determining prognosis.
  • The review covers specific CTCL subtypes that express CD8 positivity, including mycosis fungoides, lymphomatoid papulosis, and aggressive forms, underscoring the importance of combining clinical, histologic, and immunohistochemical data for accurate diagnosis and treatment.
View Article and Find Full Text PDF
Article Synopsis
  • The study explores the rare disease CD4CD56 blastic plasmacytoid dendritic cell neoplasm (BPDCN), focusing on its clinical signs, pathology, immune profiles, and treatment outcomes.
  • Two elderly male patients with BPDCN were analyzed, revealing tumors in skin, bone marrow, and lymph nodes, with specific immunohistochemical and flow cytometry profiles indicating the disease's characteristics.
  • Although both patients responded initially to chemotherapy, they faced rapid relapses, with overall survival times of 36 months and 4 months, highlighting the need for early recognition and targeted treatment strategies to improve prognosis.
View Article and Find Full Text PDF
Article Synopsis
  • Primary cutaneous lymphomas are skin-specific immune system tumors that typically do not show other symptoms outside the skin at diagnosis; research on these conditions in children and adolescents is limited.
  • This study aimed to fill the knowledge gap by examining the clinical, histological, and molecular features of pediatric patients with primary cutaneous lymphoma, resulting in the creation of the Paediatric Primary Cutaneous Lymphoma Atlas to assist in diagnosis.
  • The retrospective analysis included 101 patients, with lymphomatoid papulosis and mycosis fungoides being the most common subtypes; long-term follow-up indicated some patients face significant health challenges, with three deaths recorded due to the condition.
View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on DOCK8 deficiency (DOCK8-Def), detailing the clinical, immunological, and genetic traits of affected patients.
  • A review of 11 patients revealed that all exhibited eczema and recurrent infections, with common issues including bronchiectasis and food allergies, while some experienced rare complications like tuberculosis and neurological syndromes.
  • The research emphasizes the importance of early diagnosis of DOCK8-Def, as it can lead to better treatment options such as hematopoietic stem cell transplantation (HSCT).
View Article and Find Full Text PDF
Article Synopsis
  • Primary cutaneous anaplastic large-cell lymphoma (PC-ALCL) is a type of non-Hodgkin lymphoma that mainly affects the skin and makes up about 25% of cutaneous T-cell lymphomas.
  • It usually appears as reddish-brown nodules on the skin, sometimes developing into ulcers, and while some cases may regress, complete resolution is rare.
  • The text also describes a unique case of a 26-year-old woman with PC-ALCL who had no history of breast implants, highlighting the differences between ALK-positive and ALK-negative subtypes, particularly in breast presentations.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!